Proteasome-mediated mineralocorticoid receptor degradation attenuates transcriptional response to aldosterone

Area of Science:

• Molecular Biology
• Endocrinology
• Cellular Biology

Background:

• The ubiquitin-proteasome pathway controls protein degradation, including nuclear hormone receptors like the estrogen receptor.
• Proteasome inhibition affects estrogen receptor-mediated transcription.

Purpose of the Study:

• To investigate if the mineralocorticoid receptor (MR) is degraded by the ubiquitin-proteasome pathway.
• To determine the effect of proteasome inhibition on MR accumulation and transcriptional activity.

Main Methods:

• Ligand-dependent degradation assays for MR.
• Proteasome inhibition studies.
• Analysis of MR primary sequence for degradation motifs (PEST elements).
• Site-directed mutagenesis of candidate lysine residues (K715, K367).

Main Results:

• The mineralocorticoid receptor (MR) undergoes ligand-dependent degradation via the ubiquitin-proteasome pathway.
• Proteasome inhibition leads to increased MR protein accumulation.
• Inhibition of proteasomal degradation enhances the transcriptional response to aldosterone.
• Mutating candidate PEST element lysines (K715, K367) did not abolish MR degradation, suggesting other sites are involved.

Conclusions:

• Mineralocorticoid receptor (MR) stability is regulated by the ubiquitin-proteasome system.
• Ligand binding promotes MR degradation.
• Proteasomal degradation of MR is coupled to its transcriptional activity, influencing gene expression in response to aldosterone.